MTOR and cancer: Modulation in other signaling events such as mechanistic target of rapamycin kinase (mTOR)/p70S6K, AMP-activated protein kinase (AMPK), PI3K/AKT and p38- MAPK signaling are reported in other cancer models following treatment with BME or pure compounds[26].